Tata Consumer Products Q3 Results FY2023, PAT at Rs. 364 crores

 Tata Consumer Products Q3 Results FY2023

by Shreya Anaokar Last Updated: Feb 03, 2023 - 01:57 pm 2.2k Views

On 2nd February, Tata Consumer Products announced its results for the third quarter of FY2023.

Key Highlights:

- During the quarter, the company reported revenue from operations of Rs. 3475 crores, which increased by 8% YoY.
- For the quarter, EBITDA was reported at Rs. 458 crores
- Profit After Tax stood at Rs. 364 crores

Business Highlights:

- For the quarter, the India Packaged Beverages business recorded 9% revenue decline led by pricing corrections and demand slowdown and late onset of winter in our key markets of North and East. Coffee continued its strong performance with a revenue growth of 34% YTD.
- Tata Tea Gold Care, Chakra Gold Care, and Tata Tea Gold Darjeeling continued to see strong traction
- For the quarter, the India Foods business registered 29% revenue growth and 4% volume growth.
- The salt portfolio continued its momentum and recorded double-digit revenue growth during the quarter. The salt portfolio also continued to record market share gains
- The Tata Sampann portfolio recorded strong double-digit growth led by broad based performance across staples and dry fruits.
- Tata Soulfull continued its strong growth trajectory during the quarter. It launched an enhanced cream version of its popular ragi bites in three variants.
- Tata Soulfull continued its strong growth trajectory during the quarter. It launched an enhanced cream version of its popular ragi bites in three variants.
- Alternate channels continue to fuel our growth and innovation agenda. Modern Trade channel grew 17%, contributing to 14.8% of India business sales. The Ecommerce channel grew 34%, contributing to 8.2% of India business sales. Approximately 11% of E-commerce revenue came from NPD (New Product Development) during the quarter. 
- For the quarter, the International Beverages business revenue grew 4%
- In the UK, premiumizing black tea, and expanding into new segments in non black tea category is focused, and have put in place a clear strategy to grow our business.  
- In the USA, Tata Raasa (a Ready to Eat and Ready to Cook range developed specifically for international markets) was launched, within select ethnic channels during the quarter.
- In the branded coffee segment, Eight O’ Clock (EOC) coffee continued to hold share with K cups growing ahead of the category.
- Teapigs continued to be the fastest-growing brand in specialty tea in the USA.
- In Canada, Tetley kicked off an integrated campaign ‘Live in the Moment’ to support the earlier launch of Tetley Live teas- a range of non-black specialty teas.
- Tata Starbucks recorded strong revenue growth of 42% for the quarter, led by a revival in out of home consumption and strong store addition. Launched the first Starbucks Reserve store in India at its Flagship Mumbai location. Opened 11 new stores during Q3, and entered 2 new cities. This brought the total number of stores to 311 across 38 cities. 

Commenting on the results, Sunil D’Souza, Managing Director & CEO of Tata Consumer Products said: “We delivered strong earnings growth this quarter while balancing revenue growth and margins in an extremely challenging macroeconomic environment.

While the branded tea business in India has been impacted by demand headwinds in some of our key markets, we are putting in place measures to address some of these challenges. In our other core business of salt, we have continued to gain market share despite pricing actions taken to mitigate input cost inflation. We continued to maintain momentum on innovation with a number of new launches across our Beverages and Foods categories. Our new engines of growth- Tata Sampann, Tata Soulfull and NourishCo have continued their strong growth trajectory and collectively account for 13% of our India business now. Tata Starbucks has delivered yet another strong quarter with the addition of 47 stores across 12 cities so far this fiscal.

Our transformation journey to becoming a leading FMCG company is progressing well. We continue to expand & strengthen our reach in GT and E-commerce and modern trade channels continue to fuel our growth and innovation agenda. We have enhanced our R&D capability and infrastructure to better support our innovation agenda across categories. Going forward, we will continue to stay focused on driving consistent and profitable growth for the business.”

Share Market Today

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage


About the Author

Shreya Anaokar is a Content Writer at 5paisa. She has completed her Master’s in Finance and Graduation in Statistics from the University of Mumbai. 


Investment/Trading is subject to market risk, past performance doesn’t guarantee future performance. The risk of trading/investment loss in securities markets can be substantial. Also, the above report is compiled from data available on public platforms.
Open Free Demat Account
Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
BSE to Discontinue Stop Loss Market Orders for All Segments from October 9

Bombay Stock Exchange (BSE) has announced the discontinuation of Stop Loss Market (SL-M) orders, effective from October 9. This decision follows a recent incident involving a "freak trade" triggered by an SL-M order, which led to concerns within the trading community. The aim is to prevent erroneous order placements, whether they result from manual or algorithmic trading.

  • Oct 03, 2023
Valiant Laboratories IPO: Closing subscription details

Valiant Laboratories Ltd has a face value of ₹10 per share while the price band for the book building IPO has been set in the band of ₹133 to ₹140 per share. The final price will be discovered within this band, through the process of book building. The fresh issue portion entailed the issue of 1,08,90,000 shares (108.90 lakh shares), which at the upper price band of ₹140 per share will translate into fresh issue size of ₹152.46 crore.

  • Oct 03, 2023
Saakshi Medtech IPO: Listing day Update

Premium listing for Saakshi Medtech and Panels Ltd, then hits upper circuit Saakshi Medtech and Panels Ltd had a strong listing on 03rd October 2023, listing at a premium of 50.52%, and subsequently hitting the 5% upper circuit on

  • Oct 03, 2023